We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Tyruko
Australian Public Assessment Report
Device/Product Name
Tyruko
Active ingredients
Natalizumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2023-04610-1-1
Submission Type
Biosimilar
Decision
Approved